TCT 971: First Report of Transeptal Ballon Expandable Valve Implant after Tendyne Degeneration.
We Recommend
Disclosures
Within the last 24 months, I have had financial relationship(s) with the ineligible company or companies listed below:
- Consultant Fee/Honoraria/Speaker's Bureau - Abbott; Edwards Lifesciences; InnovHeart; Neovasc; 4Tech